AVEO Oncology
AVEO
#7043
Rank
โ‚ฌ0.44 B
Marketcap
12,91ย โ‚ฌ
Share price
0.00%
Change (1 day)
153.10%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : โ‚ฌ62.3 Million

According to AVEO Oncology 's latest financial reports the company's total liabilities are โ‚ฌ62.3 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31โ‚ฌ52.51 M104.28%
2020-12-31โ‚ฌ25.7 M-19.46%
2019-12-31โ‚ฌ31.91 M-33.81%
2018-12-31โ‚ฌ48.21 M-36.4%
2017-12-31โ‚ฌ75.81 M173.01%
2016-12-31โ‚ฌ27.76 M30.22%
2015-12-31โ‚ฌ21.32 M-48.19%
2014-12-31โ‚ฌ41.15 M-25.61%
2013-12-31โ‚ฌ55.32 M-17.33%
2012-12-31โ‚ฌ66.92 M21.55%
2011-12-31โ‚ฌ55.06 M-7.61%
2010-12-31โ‚ฌ59.6 M18.65%
2009-12-31โ‚ฌ50.23 M-58.39%
2008-12-31โ‚ฌ0.12 B6.12%
2007-12-31โ‚ฌ0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
โ‚ฌ73.96 B 118,622.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ69.30 B 111,136.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.62 B 15,348.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ8.00 B 12,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ61.56 B 98,717.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ19.51 M-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA